日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas

Botensilimab(Fc增强型抗细胞毒性淋巴细胞相关蛋白-4抗体)联合Balstilimab(抗PD-1抗体)治疗复发/难治性转移性肉瘤患者

Wilky, Breelyn A; Schwartz, Gary K; Gordon, Michael S; El-Khoueiry, Anthony B; Bullock, Andrea J; Henick, Brian; Agulnik, Mark; Singh, Arun; Mahadevan, Daruka; Stebbing, Justin; Delepine, Chloe; Chand, Dhan; Avagyan, Manushak; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven; Trent, Jonathan C; Jones, Robin L; Tsimberidou, Apostolia M

First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies

DT2216(一种选择性 BCL-xL 降解剂)在复发/难治性实体恶性肿瘤患者中的首次人体 I 期研究

Mahadevan, Daruka; Barve, Minal; Mahalingam, Devalingam; Parekh, Jay; Kurman, Michael; Strauss, James; Tremaine, Larry; Hromas, Robert; Sills, Joshua; McCulloch, John; Harkey, John; Suberg, Stacy; Zimmerman, Lisa; Zheng, Guangrong; Zhou, Daohong

Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer

在难治性卵巢癌患者中,Botensilimab(Fc增强型抗CTLA-4抗体)联合balstilimab(抗PD-1抗体)治疗方案

Porter, Rebecca; Bockorny, Bruno; Corr, Bradley R; Mahadevan, Daruka; Wilky, Breelyn A; El-Khoueiry, Anthony B; Bullock, Andrea J; Hafez, Navid; Moser, Justin; Martynova, Anastasia; Stebbing, Justin; Joshi, Bishnu; Bourdelais, Sean; Delepine, Chloe; Chand, Dhan; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven J; Matulonis, Ursula A; Gordon, Michael S

Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors

循环肿瘤DNA和组织检测在胰胆肿瘤诊断中的应用

Mahadevia, Himil; Majeed, Umair; Patel, Jaydeepbhai; Ahmed, Ahmed K; Elhariri, Ahmed; Albelal, Douaa; Rao, Nakka Naga Malleswara; Rachamala, Hari Krishnareddy; Mosalem, Osama; Mukhopadhyay, Debabrata; Jones, Jeremy; Mahadevan, Daruka; Borad, Mitesh J; Ahn, Daniel; Sonbol, Mohamad Bassam; Tran, Nguyen; Mahipal, Amit; Wee Ma, Wen; McWilliams, Robert R; Halfdanarson, Thor R; Kankeu Fonkoua, Lionel A; Bekaii-Saab, Tanios; Mody, Kabir; Babiker, Hani

Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial

Botensilimab联合balstilimab治疗复发/难治性微卫星稳定型转移性结直肠癌:一项I期试验

Bullock, Andrea J; Schlechter, Benjamin L; Fakih, Marwan G; Tsimberidou, Apostolia M; Grossman, Joseph E; Gordon, Michael S; Wilky, Breelyn A; Pimentel, Agustin; Mahadevan, Daruka; Balmanoukian, Ani S; Sanborn, Rachel E; Schwartz, Gary K; Abou-Alfa, Ghassan K; Segal, Neil H; Bockorny, Bruno; Moser, Justin C; Sharma, Sunil; Patel, Jaymin M; Wu, Wei; Chand, Dhan; Rosenthal, Katherine; Mednick, Gabriel; Delepine, Chloe; Curiel, Tyler J; Stebbing, Justin; Lenz, Heinz-Josef; O'Day, Steven J; El-Khoueiry, Anthony B

Polyploidy in Cancer: Causal Mechanisms, Cancer-Specific Consequences, and Emerging Treatments

癌症中的多倍体:致病机制、癌症特异性后果和新兴疗法

Conway, Patrick J; Dao, Jonathan; Kovalskyy, Dmytro; Mahadevan, Daruka; Dray, Eloise

CTNI-30. A PHASE 2 DOUBLE-BLIND, RANDOMIZED, PROSPECTIVE, PLACEBO CONTROLLED STUDY OF NANO₂TM COMBINED WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA: RESTORE

CTNI-30。一项针对新诊断胶质母细胞瘤患者的 NANO₂™ 联合放射治疗和替莫唑胺治疗的 II 期双盲、随机、前瞻性、安慰剂对照研究:RESTOR

Cordero, Raúl R; Feron, Sarah; Damiani, Alessandro; MacDonell, Shelley; Carrasco, Jorge; Pizarro, Jaime; Karas, Cyrus; Jorquera, Jose; Sepulveda, Edgardo; Cabello, Fernanda; Fernandoy, Francisco; Wang, Chenghao; Khan, Alia L; Casassa, Gino; Lujan, Arturo; Chakrabarti, Jayati; Eschbacher, Jennifer; Zada, Gabriel; Kim, Albert; Little, Andrew; Santagata, Sandro; Zavros, Yana; Badruddoja, Michael A; Placencia, Crystal; Unger, Evan; Gellert, Scott; Stea, Baldassarre; Peters, Katherine B; Kong, Xiao-Tang; Aiken, Robert; Goldin, Caroline; Mahadevan, Daruka; Goldlust, Samuel A

ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition

胰腺导管腺癌患者循环游离DNA中ERBB2(HER2)扩增和共存的KRAS改变与HER2抑制剂疗效的关系

Barzi, Afsaneh; Weipert, Caroline M; Espenschied, Carin R; Raymond, Victoria M; Wang-Gillam, Andrea; Nezami, Mohammad Amin; Gordon, Eva J; Mahadevan, Daruka; Mody, Kabir

Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE)

肿瘤选择性腺病毒 enadenotucirev 与 nivolumab 联合治疗晚期/转移性上皮癌患者的安全性和有效性:一项 I 期临床试验 (SPICE)

Fakih, Marwan; Harb, Wael; Mahadevan, Daruka; Babiker, Hani; Berlin, Jordan; Lillie, Tom; Krige, David; Carter, Jo; Cox, Chris; Patel, Minesh; Parfitt, Lola; Powell, Mark; Rosen, Lee

Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation

利用cfDNA和ctDNA作为肿瘤标志物:迈向临床验证之路

Dao, Jonathan; Conway, Patrick J; Subramani, Baskaran; Meyyappan, Devi; Russell, Sammy; Mahadevan, Daruka